Search Results - "FOO, KIAN FONG"

The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma by Ang, Soo Fan, Ng, Elizabeth Shu-Hui, Li, Huihua, Ong, Yu-Han, Choo, Su Pin, Ngeow, Joanne, Toh, Han Chong, Lim, Kiat Hon, Yap, Hao Yun, Tan, Chee Kiat, Ooi, London Lucien Peng Jin, Cheow, Peng Chung, Chung, Alexander Yaw Fui, Chow, Pierce Kah Hoe, Foo, Kian Fong, Tan, Min-Han

“…Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). Current prognostic models for HCC are developed on datasets of…”
Get full text

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma by Huynh, Hung, Pierce Chow, K.H., Soo, Khee Chee, Toh, Han Chong, Choo, Su Pin, Foo, Kian Fong, Poon, Donald, Ngo, Van Chanh, Tran, Evelyn

“…Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and highly resistant to available chemotherapies. Mammalian target of rapamycin…”
Get full text

Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients by HAN CHONG TOH, WANG, Who-Whong, KIAN FONG FOO, SIMON ONG, WEN HSIN KOO, ZOCCA, Mai-Britt, CLAESSON, Mogens H, WHAY KUANG CHIA, KVISTBORG, Pia, LI SUN, TEO, Kelly, YEE PENG PHOON, SOE, Yatanar, SZE HUEY TAN, SIEW WAN HEE

“…Purpose: We evaluated the clinical benefit of an allogeneic melanoma cell lysate (MCL)–pulsed autologous dendritic cell (DC) vaccine in advanced colorectal…”
Get full text

Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Pancreatic Adenocarcinoma

“…The SCAN pancreatic cancer workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for systemic therapy for pancreatic…”
Get more information

Correction: The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma by Ang, Soo Fan, Ng, Elizabeth Shu-Hui, Li, Huihua, Ong, Yu-Han, Choo, Su Pin, Ngeow, Joanne, Toh, Han Chong, Lim, Kiat Hon, Yap, Hao Yun, Tan, Chee Kiat, Ooi, London Lucien Peng Jin, Cheow, Peng Chung, Chung, Alexander Yaw Fui, Chow, Pierce Kah Hoe, Foo, Kian Fong, Tan, Min-Han

Get full text

Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma by Ang, Soo-Fan, Tan, Sze-Huey, Toh, Han-Chong, Poon, Donald Y H, Ong, Simon Y K, Foo, Kian-Fong, Choo, Su-Pin

“…Thalidomide has shown modest activity in advanced hepatocellular carcinomas (HCCs). Single-agent capecitabine has also been used in patients with HCC, with…”
Get full text

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer by Chang, Alex Yuang-Chi, Foo, Kian Fong, Koo, Wen-Hsin, Ong, Simon, So, Jimmy, Tan, Daniel, Lim, Khong Hee

“…BackgroundNeoadjuvant chemotherapy improves survival of locally advanced gastric cancer patients. However, benefit is limited and the best regimen remains…”
Get full text

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A phase II trial using a triplet combination by LEONG, Swan-Swan, WEE, Joseph, MIAH HIANG TAY, CHEE KEONG TOH, SAY BENG TAN, CHOON HUA THNG, KIAN FONG FOO, WAN TECK LIM, TAN, Terence, ENG HUAT TAN

“…Patients with nasopharyngeal carcinoma (NPC) are treated primarily with radiotherapy. In the disseminated state, platinum-based, 2-drug combination regimens…”
Get full text

Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer by Leong, Swan Swan, Tan, Eng Huat, Fong, Kam Weng, Wilder-Smith, Einar, Ong, Yew Kwang, Tai, Bee Choo, Chew, Lita, Lim, Shih Hui, Wee, Joseph, Lee, Khai Mun, Foo, Kian Fong, Ang, Peter, Ang, Peng Tiam

“…Greater toxicities have been recognized to be a consequence of combined chemotherapy and radiotherapy in the treatment of locally advanced non-small-cell lung…”
Get full text

Gastrointestinal stromal tumour in the elderly by Tham, Chee-Kian, Poon, Donald Yew-Hee, Li, Hui-Hua, Tan, Min-Han, Choo, Su-Pin, Foo, Kian-Fong

“…Abstract Aim To analyze the outcome of elderly patients compared with the younger age group patients who were diagnosed with gastrointestinal stromal tumours…”
Get full text

Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer by Quek, Richard, Lim, Wan Teck, Foo, Kian Fong, Koo, Wen Hsin, A-Manaf, Afidah, Toh, Han Chong

Get more information

The not so innocuous abdominal tap by Wong, Chee-Wai, Choo, Su-Pin, Foo, Kian-Fong

Get full text

Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group Study by Chang, Alex Y, Lopes, Gilberto, Hsin, Koo Wen, Lim, Robert, Fong, Foo Kian, Wong, John

“…Abstract Background Second-line treatment of relapsed or metastatic colorectal cancer (CRC) after failure of treatment with a fluoropyrimidine is composed of…”
Get full text

Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma by Chia, Whay Kuang, Ong, Simon, Toh, Han Chong, Hee, Siew Wan, Choo, Su Pin, Poon, Donald Y H, Tay, Miah Hiang, Tan, Chee Kiat, Koo, Wen Hsin, Foo, Kian Fong

“…Advanced hepatocellular carcinoma (HCC) has a dismal prognosis and is notoriously chemo-resistant. We conducted a Phase II prospective study to evaluate the…”
Get more information

Induction concurrent chemoradiotherapy using Paclitaxel and Carboplatin combination followed by surgery in locoregionally advanced non-small cell lung cancer--Asian experience by Yap, Swee-Peng, Lim, Wan-Teck, Foo, Kian-Fong, Hee, Siew-Wan, Leong, Swan-Swan, Fong, Kam-Weng, Eng, Philip, Hsu, Anne Al, Wee, Joseph Ts, Agasthian, Thirugnanam, Koong, Heng-Nung, Tan, Eng-Huat

“…It has been established that combined chemoradiotherapy treatment benefits selected patients with stage III Non Small Cell Lung Cancer (NSCLC). However,…”
Get more information

A new chemoimmunotherapy regimen (OXAFI) for advanced hepatocellular carcinoma by Ang, Mei-Kim, Poon, Donald, Foo, Kian-Fong, Chung, Yaw-Fui, Chow, Pierce, Wan, Wei-Keat, Thng, Choon-Hua, Ooi, London

“…BACKGROUND Chemotherapeutic treatment options for advanced unresectable and/or metastatic hepatocellular carcinoma (Hcc) are limited. currently available…”
Get full text

Chemo-radiotherapy for stage III unresectable non-small cell lung cancer—long-term results of a prospective study by Leong, Swan Swan, Fong, Kam Weng, Ong, Yew Kwang, Foo, Kian Fong, Ang, Peter, Wee, Joseph, Lee, Khai Mun, Tan, Eng Huat

“…Introduction: Combined-modality treatment is considered standard of care in the treatment of stage III non-small-cell lung cancer (NSCLC). This study was…”
Get full text

The Singapore Liver Cancer Recurrence by Ang, Soo Fan, Ng, Elizabeth Shu-Hui, Li, Huihua, Ong, Yu-Han, Choo, Su Pin, Ngeow, Joanne, Toh, Han Chong, Lim, Kiat Hon, Yap, Hao Yun, Tan, Chee Kiat, Ooi, London Lucien Peng Jin, Chung, Alexander Yaw Fui, Chow, Pierce Kah Hoe, Foo, Kian Fong, Tan, Min-Han, Cheow, Peng Chung

“…Background and Aims Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). Current prognostic models for HCC are developed on…”
Get full text

Capecitabine with radiation is an effective adjuvant therapy in gastric cancers by Tham, Chee Kian, Choo, Su Pin, Poon, Donald Yew Hee, Toh, Han Chong, Ong, Simon Yew Kuang, Tan, Sze Huey, Wang, Michael Lian Chek, Foo, Kian Fong

“…To analyze the outcome of patients who received concurrent capecitabine (Xeloda) and radiation (XRT) compared to the established concurrent 5-fluorouracil…”
Get full text

A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly by Leong, Swan Swan, Toh, Chee Keong, Lim, Wan Teck, Lin, Xu, Tan, Say Beng, Poon, Donald, Tay, Miah Hiang, Foo, Kian Fong, Ho, Juliana, Tan, Eng Huat

“…Patients with poor performance status and/or are elderly are frequently considered a compromised group at high risk of chemotherapy-related morbidities and…”
Get more information